Literature DB >> 20832179

Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy.

Masamitsu Hatakenaka1, Katsumasa Nakamura, Hidetake Yabuuchi, Yoshiyuki Shioyama, Yoshio Matsuo, Kayoko Ohnishi, Shunya Sunami, Takeshi Kamitani, Taro Setoguchi, Takashi Yoshiura, Torahiko Nakashima, Kei Nishikawa, Hiroshi Honda.   

Abstract

PURPOSE: This study was performed to evaluate whether the apparent diffusion coefficient (ADC) of a primary lesion correlates with local failure in primary head-and-neck squamous cell carcinoma (HNSCC) treated with chemoradiotherapy or radiotherapy. METHODS AND MATERIALS: We retrospectively studied 38 patients with primary HNSCC (12 oropharynx, 20 hypopharynx, 4 larynx, 2 oral cavity) treated with chemoradiotherapy or radiotherapy with radiation dose to gross tumor volume equal to or over 60 Gy and who underwent pretreatment magnetic resonance imaging, including diffusion-weighted imaging. Ten patients developed local failure during follow-up periods of 2.0 to 9.3 months, and the remaining 28 showed local control during follow-up periods of 10.5 to 31.7 months. The variables that could affect local failure (age, tumor volume, ADC, T stage, N stage, dose, treatment method, tumor location, and overall treatment time) were analyzed using logistic regression analyses for all 38 patients and for 17 patients with Stage T3 or T4 disease.
RESULTS: In univariate logistic analysis for all 38 cases, tumor volume, ADC, T stage, and treatment method showed significant (p < 0.05) associations with local failure. In multivariate analysis, ADC and T stage revealed significance (p < 0.01). In univariate logistic analysis for the 17 patients with Stage T3 or T4 disease, ADC and dose showed significant (p < 0.01) associations with local failure. In multivariate analysis, ADC alone showed significance (p < 0.05).
CONCLUSIONS: The results suggest that pretreatment ADC, along with T stage, is a potential indicator of local failure in HNSCC treated with chemoradiotherapy or radiotherapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20832179     DOI: 10.1016/j.ijrobp.2010.05.051

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  36 in total

1.  [Image-guided radiation therapy].

Authors:  J Boda-Heggemann; M Guckenberger; U Ganswindt; C Belka; H Wertz; M Blessing; F Wenz; M Fuss; F Lohr
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

2.  Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Authors:  C S Schouten; P de Graaf; E Bloemena; B I Witte; B J M Braakhuis; R H Brakenhoff; C R Leemans; J A Castelijns; R de Bree
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-26       Impact factor: 3.825

3.  Functional imaging to predict treatment response after (chemo) radiotherapy of head and neck squamous cell carcinoma.

Authors:  Remco de Bree
Journal:  Quant Imaging Med Surg       Date:  2013-10

4.  Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.

Authors:  Shu-Hang Ng; Chun-Ta Liao; Chien-Yu Lin; Sheng-Chieh Chan; Yu-Chun Lin; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Kang-Hsing Fan; Hung-Ming Wang; Lan-Yan Yang; Jiun-Jie Wang
Journal:  Eur Radiol       Date:  2016-02-24       Impact factor: 5.315

5.  Apparent diffusion coefficient calculated with relatively high b-values correlates with local failure of head and neck squamous cell carcinoma treated with radiotherapy.

Authors:  M Hatakenaka; Y Shioyama; K Nakamura; H Yabuuchi; Y Matsuo; S Sunami; T Kamitani; T Yoshiura; T Nakashima; K Nishikawa; H Honda
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-21       Impact factor: 3.825

Review 6.  The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective.

Authors:  Kee H Wong; Rafal Panek; Shreerang A Bhide; Christopher M Nutting; Kevin J Harrington; Katie L Newbold
Journal:  Br J Radiol       Date:  2017-03       Impact factor: 3.039

7.  Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemiotherapy treated head and neck squamous cell carcinoma.

Authors:  Mariangela Lombardi; Teresa Cascone; Elena Guenzi; Alessandro Stecco; Francesco Buemi; Marco Krengli; Alessandro Carriero
Journal:  Radiol Med       Date:  2017-02-10       Impact factor: 3.469

8.  Characterization and therapy monitoring of head and neck carcinomas using diffusion-imaging-based intravoxel incoherent motion parameters-preliminary results.

Authors:  Thomas Hauser; Marco Essig; Alexandra Jensen; Lars Gerigk; Frederik Bernd Laun; Marc Münter; Dirk Simon; Bram Stieltjes
Journal:  Neuroradiology       Date:  2013-02-17       Impact factor: 2.804

9.  Apparent diffusion coefficient is a prognostic factor of head and neck squamous cell carcinoma treated with radiotherapy.

Authors:  Masamitsu Hatakenaka; Katsumasa Nakamura; Hidetake Yabuuchi; Yoshiyuki Shioyama; Yoshio Matsuo; Takeshi Kamitani; Masato Yonezawa; Takashi Yoshiura; Torahiko Nakashima; Mitsuru Mori; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2014-01-10       Impact factor: 2.374

10.  Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation.

Authors:  M Ravanelli; A Grammatica; M Maddalo; M Ramanzin; G M Agazzi; E Tononcelli; S Battocchio; P Bossi; M Vezzoli; R Maroldi; D Farina
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.